Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Apr 29, 2022
9 Tips for Building a Crypto Portfolio

9 Tips for Building a Crypto Portfolio

It’s a unique time to begin investing in cryptocurrency. Price fluctuations, constantly-emerging new varieties of coins, and an influx of investors curious about the potential of digital currency all indicate that interest has never been higher – nor has the investment landscape been more confusing. Here are eight tips to help you wade through the mire and begin intelligently investing in cryptocurrencies.

Tip #1: Pay Attention to Circulation Supply, Total Supply, and Market Cap

Looking at these three market factors can help paint a picture of a coin’s potential. Circulation supply and total supply go hand-in-hand, providing useful insights into the likelihood of a coin increasing in value over time – for example, the greater the number of coins and the faster they are brought into circulation, the harder it could be for a coin to climb in price. A massive total supply often indicates that prices will stabilize as circulation supply expands, as increased circulation offsets rising prices. Similarly, the market cap allows us to estimate future growth for coins – comparing market caps between various cryptocurrencies offers useful benchmarks to gauge a coin’s potential.

Tip #2: Diversify Your Portfolio

Diversification almost always makes for good investment strategy, period. But it’s especially true for cryptocurrency, where disruption is the name of the game – new technologies, mining algorithms, and more can pop-up out of nowhere, cause a stir, and disappear in the blink of an eye. Diversifying your investments with a range of market caps, target markets, and coin technologies can potentially reduce risk while providing diverse sources of return – in the spirit of insulating you from the more chaotic effects of the market.  

Tip #3: Do Thorough Research

No one regrets doing some solid research before investing. When considering coins, evaluate the team behind them – it’s never been easier with LinkedIn, Facebook, and other social and professional networks. Who are the advisors? What about the investors? How much funding do they have, and how did they obtain it? These things will give you a picture of the health of a company, as well as a potential trajectory. Flash and hype are exciting, but a diverse team with strong experience, a proven track record of success, and backing from prominent VC firms or investors is far more likely to develop a successful coin.

Tip #4: Evaluate the Code

The public code repositories behind each cryptocurrency are a wealth of information for a crypto investor. Evaluating these repositories can tell us how often code is committed, the number (and severity) of any reported issues, how many developers are contributing commits, and more. Too few commits, or too few developers, usually means a coin is unsustainable. The code itself is also a useful source of information – clean, well-documented code is, at the minimum, a sign of competence. Bonus points if developers engage with the community via social media, speak at conferences, and more.

Tip #5: Read the Whitepaper Closely

The vision articulated in a whitepaper is a window into coin creators’ ambitions, but it shouldn’t be treated as the word of law. Whitepapers have a tendency towards grand language and ideas, which makes for exciting reading, but if a coin is trying to do everything or lacks details, it often portends a lack of technical know-how or a one-way ticket to dried-up funding. Look for whitepapers emphasizing a practical approach, as well as an understanding of cryptocurrency and the current technologies making up its foundation.

Tip #6: Gauge the Community Involvement

Like any product, coins need a community of purchasers, advocates, and users behind them to succeed – the greatest coin in the world on paper would be valueless without adoption. An active, engaged group of users, which you can gauge through social media and discussion boards, bodes well for a successful coin. It is an especially good sign when third parties begin building functions and integrations supporting a coin. A coin with a growing market cap should have a community growing alongside it – if market cap outstrips support, proceed with caution.

Tip #7: Assess the Hype Machine

We’ve been discouraging you from paying too much attention to hype, but don’t discount it entirely – it is often a byproduct of strong marketing, and strong marketing is key to a successful coin. That said, bells and whistles with no substance means that, as funding dwindles, so does the product’s opportunity for success. Product development and marketing working in lockstep is ideal, and organically successful marketing campaigns are also positive.

 

 

Tip #8: Watch the Timeline

Reasonable timelines and teams that deliver on them are good signs to an investor. This means a team is functioning well, reaching its objectives, and taking a realistic approach to their product’s development. Falling short of benchmarks is okay, but transparency is key – teams that provide an explanation for failure, as well as evidence to support it, are teams that take ownership of their process and want to be held accountable. Radio silence and constantly missed deadlines are big red flags.  

Tip #9: Invest with the Help of Artificial Intelligence

If you’ve never unleashed the power of algorithms and AI for discovering patterns in the cryptocurrency markets before, perhaps it’s because it has never been available to retail investors in an easy-to-use format. Tickeron has created AI that can provide retail investors with technology and tools to enable trading with massive amounts of data and analysis. The end result is arming retail investors with a high-powered, virtual research assistant: Tickeron’s Artificial Intelligence.

Learn more about how the AI works by exploring the features of Tickeron’s Pattern Search Engine.

Related Ticker: BTC.X

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


BTC.X sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for BTC.X moved above the 200-day moving average on September 08, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 03, 2026. You may want to consider a long position or call options on BTC.X as a result. In 42 of 145 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 29%.

Following a +2.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where BTC.X advanced for three days, in 124 of 424 cases, the price rose further within the following month. The odds of a continued upward trend are 29%.

The Aroon Indicator entered an Uptrend today. In 113 of 380 cases where BTC.X Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 30%.

Bearish Trend Analysis

The 10-day RSI Indicator for BTC.X moved out of overbought territory on October 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 11 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 25%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 24 of 92 cases where BTC.X's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 26%.

The Moving Average Convergence Divergence Histogram (MACD) for BTC.X turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 66 similar instances when the indicator turned negative. In 16 of the 66 cases the stock turned lower in the days that followed. This puts the odds of success at 24%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BTC.X declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 30%.

BTC.X broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Market Cap

The average market capitalization across the group is 1.72T. The market cap for tickers in the group ranges from 1.72T to 1.72T. BTC.X holds the highest valuation in this group at 1.72T. The lowest valued company is BTC.X at 1.72T.

High and low price notable news

The average weekly price growth across all stocks in the group was 3%. For the same group, the average monthly price growth was 7%, and the average quarterly price growth was 21%. BTC.X experienced the highest price growth at 3%, while BTC.X experienced the biggest fall at 3%.

Volume

The average weekly volume growth across all stocks in the group was -29%. For the same stocks of the group, the average monthly volume growth was 63% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating:
P/E Growth Rating:
Price Growth Rating:
SMR Rating:
Profit Risk Rating:
Seasonality Score: (-100 ... +100)
View a ticker or compare two or three
BTC.X
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.